| Overall (N=99) |
|
|---|---|
| Age (years) | |
| Mean (SD) | 55.1 (10.2) |
| Median [Min, Max] | 55.0 [24.0, 82.0] |
| Operation_history | |
| Direct_surgery | 66 (66.7%) |
| Septal_tumor_reduction | 1 (1.0%) |
| Surgery_after_neoadjuvant | 32 (32.3%) |
| Type | |
| CCC | 2 (2.0%) |
| EC | 3 (3.0%) |
| HGSC | 89 (89.9%) |
| LGSC | 2 (2.0%) |
| MC | 2 (2.0%) |
| Missing | 1 (1.0%) |
| Clinical_stage | |
| I | 1 (1.0%) |
| II | 8 (8.1%) |
| III | 45 (45.5%) |
| IV | 45 (45.5%) |
| TMB_group | |
| High | 5 (5.1%) |
| Low | 92 (92.9%) |
| Missing | 2 (2.0%) |
| Planting_metastasis | |
| No | 7 (7.1%) |
| Yes | 92 (92.9%) |
| Lymph.node_metastasis | |
| No | 41 (41.4%) |
| Yes | 58 (58.6%) |
| Relapse_within_6months | |
| Yes | 13 (13.1%) |
| No | 64 (64.6%) |
| Unknown | 22 (22.2%) |